DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Pompe RS, Tilki D, Preisser F. et al.
Survival benefit of local versus no local treatment for metastatic prostate
cancer – impact of baseline PSA and metastatic substages.
Prostate 2018;
78: 753-757
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.